Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers
- PMID: 12820473
Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers
Abstract
Purpose: To investigate and compare the diagnostic value of the detection of cytokeratin 19 (CK-19), carcinoembryonic antigen (CEA) and maspin mRNA by nested RT-PCR in the peripheral blood of women with breast cancer.
Materials and methods: The tumor cell lines MCF-7 and LOVO were used in an experimental tumor cell dilution model to determine the sensitivity of the nested RT-PCR for the 3 detection markers. RT-PCR analysis was performed in the peripheral blood of 54 healthy female blood donors, 28 patients with hematological malignancies, 31 with metastatic colorectal cancer, 75 with operable and 50 with metastatic breast cancer before receiving any cytotoxic chemotherapy, as well as in the bone marrow aspirates of 61 breast cancer patients.
Results: Nested RT-PCR for CK-19 mRNA presented the highest sensitivity by detecting 1 tumor cell amongst 10(6) PBMC in 4 out of 5 experiments. CK-19 mRNA was detected in the peripheral blood of 3.7% of female blood donors, 14.3% of hematological malignancies, 32% of operable and 42% of metastatic breast cancer patients. CEA mRNA was undetectable in the blood of female blood donors but was detected in blood samples of 3.5% of hematological malignancies, 19.3% of colorectal cancer and 10% of breast cancer patients. Maspin mRNA was undetectable in the blood of female blood donors, patients with hematological malignancies and colorectal cancer but was detected in 9.3% of operable and 14% of metastatic breast cancer patients. Maspin mRNA positivity correlated with tumor size in patients with early stage breast cancer (p = 0.057). The detection rates of CK-19 and maspin mRNA in bone marrow aspirates were 33% and 11% for operable and 62% and 9% for metastatic breast cancer, respectively. During follow-up, 27.4% of blood samples were positive for CK-19 mRNA versus 10.7% for maspin mRNA in patients with operable breast cancer with a concordance rate of only 12.7% for positives and 86% for negatives.
Conclusion: RT-PCR positivity for CK-19 mRNA is the most sensitive detection marker for occult tumor cells in operable and metastatic breast cancer, although nested RT-PCR for maspin mRNA appears to be more specific.
Similar articles
-
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.Cancer Res. 2001 Mar 15;61(6):2523-32. Cancer Res. 2001. PMID: 11289125
-
Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.Clin Cancer Res. 2003 Nov 1;9(14):5145-51. Clin Cancer Res. 2003. PMID: 14613993
-
Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.Cancer Res. 2001 Dec 15;61(24):8845-50. Cancer Res. 2001. PMID: 11751407
-
Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.In Vivo. 2000 Jan-Feb;14(1):237-50. In Vivo. 2000. PMID: 10757082 Review.
-
[Clinical significance of detecting circulating cancer cells in patients with solid malignancies].Gan To Kagaku Ryoho. 2001 Jun;28(6):769-75. Gan To Kagaku Ryoho. 2001. PMID: 11432343 Review. Japanese.
Cited by
-
The most likely but largely ignored triggering factor for breast (or all) cancer invasion.J Cancer. 2023 Feb 27;14(4):573-590. doi: 10.7150/jca.82291. eCollection 2023. J Cancer. 2023. PMID: 37057291 Free PMC article.
-
Clinical significance of circulating tumor cell related markers in patients with epithelial ovarian cancer before and after adjuvant chemotherapy.Sci Rep. 2021 May 18;11(1):10524. doi: 10.1038/s41598-021-88780-w. Sci Rep. 2021. PMID: 34006887 Free PMC article.
-
Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.Histopathology. 2009 Apr;54(5):590-7. doi: 10.1111/j.1365-2559.2009.03260.x. Epub 2009 Mar 20. Histopathology. 2009. PMID: 19309490 Free PMC article.
-
Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay.Breast Cancer (Dove Med Press). 2021 Nov 16;13:617-624. doi: 10.2147/BCTT.S337075. eCollection 2021. Breast Cancer (Dove Med Press). 2021. PMID: 34815711 Free PMC article.
-
Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands.Sci Rep. 2022 May 20;12(1):8555. doi: 10.1038/s41598-022-12118-3. Sci Rep. 2022. PMID: 35595733 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials